On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.
More Latest News
April 17, 2018
Click here to view a full list of bill summaries from the 2018 Florida Legislative Session that may impact your profession. Continue reading
April 15, 2018
The Quarterly Performance Report for the first quarter of the 2017-2018 fiscal year is now available online. Continue reading